Plasma brain natriuretic peptide is associated with hepatic veno-occlusive disease and early mortality after allogeneic hematopoietic stem cell transplantation
Authors:
Open Access
- 22 February 2010
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 45 (11) , 1631-1637
Abstract
Fluid retention is characteristic of veno-occlusive disease (VOD). We hypothesized that plasma brain natriuretic peptide (BNP), a neurohormone secreted in response to volume expansion, may be associated with VOD after hematopoietic stem cell transplantation (HSCT). BNP was measured before and weekly after HSCT in 46 recipients. Sixteen patients developed VOD. BNP concentrations were similar before and on day 0 in patients with and without VOD, but were significantly higher on day 7 and later in those with VOD. Patients with VOD had significantly higher peak BNP concentrations before engraftment than those without VOD (median, 634.4 versus 80.9 pg ml−1; P=0.01). Multivariate analysis showed that VOD was independently associated with BNP elevation (odds ratio, 50.1; 95% CI: 5.2–478.4; P−1 had significantly worse 100-day survival than patients with peak BNP −1 (54 versus 91%; PP=0.03). These findings suggest that plasma BNP may serve as a diagnostic and prognostic marker of VOD.Keywords
This publication has 28 references indexed in Scilit:
- Stress-Related Cardiomyopathy SyndromesCirculation, 2008
- Cardiac and cardiovascular consequences after haematopoietic stem cell transplantationBritish Journal of Haematology, 2008
- Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock*Critical Care Medicine, 2007
- Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinaseJournal of Molecular and Cellular Cardiology, 2004
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaNew England Journal of Medicine, 2004
- Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcomeBlood, 2002
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Practical implications of current natriuretic peptide researchJournal of the Renin-Angiotensin-Aldosterone System, 2000
- Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptideBone Marrow Transplantation, 2000
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992